Newrology: Summary

Newrology

Pharmaceutical, healthcare, neurology, rare diseases

Harmony Biosciences is dedicated to advancing the landscape of rare neurological diseases through innovative therapies and a deep understanding of patient needs.

Newrology is a patient-focused drug development model by Harmony Biosciences that utilizes patient insights to inform clinical research programs. It aims to address unmet medical needs in the realm of rare neurological disorders.

Patient-focused drug development model; Utilizes patient insights for clinical research; Commitment to addressing unmet medical needs; Focus on rare neurological disorders

Newrology is most valuable for patients suffering from rare neurological disorders, particularly those who have been undiagnosed or misdiagnosed for years.

Strong focus on rare neurological disorders; Empathetic approach to patient needs; Robust pipeline of innovative therapies

The company has a strong commitment to innovation and patient care, demonstrated by its recent acquisition of Epygenix Therapeutics and its successful revenue growth.

Harmony Biosciences positions itself as a leader in the development of therapies for rare neurological diseases, emphasizing its patient-centric approach.

The target users include patients with rare neurological disorders, caregivers, and healthcare professionals seeking innovative treatment options.

Learn More

• neurology

• patient care

• innovation

• rare diseases

A fresh approach to helping patients thrive

Empathetic, innovative, committed

Harmony Biosciences stands out by integrating patient insights into their drug development process, ensuring that their therapies are closely aligned with the actual needs and experiences of patients.

The brand identity of Harmony Biosciences is rooted in empathy and innovation, focusing on the cultivation of therapies that address significant medical needs.

2017-10-01

• Jeff Aronin